Close

Anticoagulants might ascend stroke attack factor among elders with chronic Kidney Disease

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

AI in Patient Engagement Clocking Around 22% CAGR by 2029

AI in patient engagement – market size in 2029 Let...

Medical Device Manufacturers to Boost in Saudi Arabia

The Ministry of Industry and Mineral Resources of Saudi...

China Puts Curbs on Medical Devices Imported from the EU

The Ministry of Finance in China on July 10...

The New Tariffs Lead To US Medical Device Costs Surge

The new round of tariffs by President Donald Trump,...

For older patients with concomitant chronic kidney disease and a new diagnosis of atrial fibrillation, anticoagulants are associated with increased risk for ischemic stroke and hemorrhage, but with reduced risk for all-cause mortality, according to a study published in The BMJ.

Shankar Kumar, MBBS, from University College London, and colleagues conducted a propensity-matched population-based cohort analysis from January 2006 through December 2016. Participants were aged 65 years and older with a new diagnosis of atrial fibrillation and estimated glomerular filtration rate of <50 mL/min/1.73 m². Using propensity-score matching, 2434 pairs of patients who were and were not on anticoagulants within 60 days of diagnosis were included.

The researchers found that the crude rates for ischemic stroke and hemorrhage were 4.6 and 1.2 per 100 person-years after taking anticoagulants and 1.5 and 0.4 in patients not taking anticoagulants.

Compared with those who received no anticoagulation, the hazard ratios for ischemic stroke, hemorrhage, and all-cause mortality were 2.60, 2.42, and 0.82, respectively, in individuals who were given anticoagulants.

“Giving anticoagulants to older people with concomitant atrial fibrillation and chronic kidney disease was associated with an increased rate of ischemic stroke and hemorrhage but a paradoxical lowered rate of all-cause mortality,” the authors wrote. “Careful consideration should be given before starting anticoagulants in older people with chronic kidney disease who develop atrial fibrillation.”

Latest stories

Related stories

AI in Patient Engagement Clocking Around 22% CAGR by 2029

AI in patient engagement – market size in 2029 Let...

Medical Device Manufacturers to Boost in Saudi Arabia

The Ministry of Industry and Mineral Resources of Saudi...

China Puts Curbs on Medical Devices Imported from the EU

The Ministry of Finance in China on July 10...

The New Tariffs Lead To US Medical Device Costs Surge

The new round of tariffs by President Donald Trump,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back